Finance
Results: 24505-24516 of 49946

Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025

Miami International Holdings Reports Trading Results for April 2025; Record Monthly and YTD Volume and Market Share across Multiple Exchanges as Options Volume Jumps 33.8%








